1 active trials 0 recruiting 1 Phase 3 1 disease areas
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT04849728 | A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active… | NASH - Nonalcoholic Steatohepatitis | Active, Not Recruiting | 2026-07-02 |
NASH / MASH (1)